V K Chiu
Overview
Explore the profile of V K Chiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiss J, Csoszi T, Maglakelidze M, Hoyer R, Beck J, Domine Gomez M, et al.
Ann Oncol
. 2019 Sep;
30(10):1613-1621.
PMID: 31504118
Background: Chemotherapy-induced damage of hematopoietic stem and progenitor cells (HSPC) causes multi-lineage myelosuppression. Trilaciclib is an intravenous CDK4/6 inhibitor in development to proactively preserve HSPC and immune system function during...
2.
Pietrantonio F, Di Nicolantonio F, Schrock A, Lee J, Morano F, Fuca G, et al.
Ann Oncol
. 2018 Mar;
29(6):1394-1401.
PMID: 29538669
Background: Recognition of rare molecular subgroups is a challenge for precision oncology and may lead to tissue-agnostic approval of targeted agents. Here we aimed to comprehensively characterize the clinical, pathological...
3.
Choy E, Chiu V, Silletti J, Feoktistov M, Morimoto T, Michaelson D, et al.
Cell
. 1999 Jul;
98(1):69-80.
PMID: 10412982
We show that Nras is transiently localized in the Golgi prior to the plasma membrane (PM). Moreover, green fluorescent protein (GFP)-tagged Nras illuminated motile, peri-Golgi vesicles, and prolonged BFA treatment...
4.
Chiu V, Walsh C, Liu C, Reed J, Clark W
J Immunol
. 1995 Mar;
154(5):2023-32.
PMID: 7532659
The ability of bcl-2 in target cells to block cell-mediated cytotoxicity by allospecific CTL was tested. The blocking effect was variable. Because killing by CTL involves two different pathways, degranulation...